ENTERPRISE DEV(01808): Liang Liang resigns as Executive Director and Co-Chief Executive Officer

27/12/2024

GMT Eight

Enterprise DEV (01808) announced that Mr. Liang Liang (Mr. Liang), due to recent health reasons of family members and other factors, has therefore resigned from his position as Executive Director and Co-CEO, effective from January 24, 2025.

New stock news | Aerospace Port's Hong Kong IPO prospectus invalidated, the company is the world's largest supplier of sea buckthorn products.

KWUNGS AROMA (01925): Ningbo Kwungs intends to separately redeem the remaining interests in the second fund and the first fund.

Contact: contact@gmteight.com

ENTERPRISE DEV(01808): Liang Liang resigns as Executive Director and Co-Chief Executive Officer

RECOMMEND

The US FDA approves Bristol-Myers Squibb Company's cancer drug Opdivo injection.

New Stock Analysis | Saimu Technology: Loss of about RMB 4.6 million in the first half of the year, anxiety of ICV testing track leader fully revealed.

Breakthrough and Metaphor of Contemporary Amperex Technology's Listing in Hong Kong